跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAGNESIUM CHLORIDE FOR HEMODIALYSIS 5.15 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MAGNESIUM CHLORIDE FOR HEMODIALYSIS 5.15
Authorized
STANDARD
MAGNESIUM CHLORIDE FOR HEMODIALYSIS 5.15
chief medical supplies ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
145c1e921bfca7f6
Company
chief medical supplies ltd
Type
Standard
Approval Details
Approval Id
145c1e921bfca7f6
Drug Approval Canada Name
MAGNESIUM CHLORIDE FOR HEMODIALYSIS 5.15
Product Name
MAGNESIUM CHLORIDE FOR HEMODIALYSIS 5.15
Status
Marketed
Status Date
2023-02-16
Original Market Date
2023-02-16
Din
02528193
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Haemodialysis
Schedule
Ethical
Ahfs
40:34.00*
Atc Original
B05ZA HEMODIALYTICS, CONCENTRATES
Atc Name
b 05 za
Aig Number
0120793031
Company Name
chief medical supplies ltd
Company Address
411 19th St Se, Calgary, Alberta, Canada, T2E 6J7
Active Ingredients
MAGNESIUM CHLORIDE (MAGNESIUM CHLORIDE)
5.15 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
145c1e921bfca7f6
Type
Standard
Back to Health Canada Approvals